{"SPADE_UN_11720": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_11720", "Peptide Name": "StigA16", "Source": "Synthetic construct", "Family": "Derived from scorpion venom peptide", "Gene": "Not found", "Sequence": "FFKLIPKLVKGLISAFK", "Sequence Length": 17, "UniProt Entry": "No entry found", "Protein Existence": "Synthetic", "Biological Activity": ["Antimicrobial", "Antibacterial", "Anti-Gram+", "Anti-Gram-", "Antifungal", "Antiparasitic", "Antiproliferative"], "Target Organism": "[Ref.29670004] Gram-positive bacteria:Staphylococcus aureus ATCC 29213 (MIC=2.34 μM), Staphylococcus epidermidis ATCC 122225 (MIC=9.38 μM), Enterococcus faecalis ATCC 4028 (MIC=1.17 μM);Gram-negative bacteria:Escherichia coli ATCC 25922 (MIC=2.34 μM), Enterobacter cloacae ATCC 13047 (MIC=9.38 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=1.17 μM);yeasts:Candida albicans ATCC 90028 (MIC=4.69 μM), Candida krusei ATCC 6258 (MIC=9.38 μM), Candida glabrata ATCC 90030 (MIC=9.38 μM);StigA16 inhibit 100% of the epimastigote forms of Trypanosoma cruzi growth at 2.5 µM;HeLa cell line:IC50=13.01 µM", "Hemolytic Activity": "[Ref.29670004] Hemolysis 0% at 1.17 [Ref.29670004] Hemolysis 0% at 1.17 μM, hemolysis 2% at 2.34 μM, hemolysis 10% at 4.69 μM, hemolysis 20% at 9.38 μM, hemolysis 35% at 18.75 μM, hemolysis 37% at 37.50 μM, hemolysis 40% at 75.00 μM against human red blood cells", "Cytotoxicity": "[Ref.29670004] The cell viability of HeLa cell lines is 15%, 21%, 16%, 9%, 8%, 10% and 11% at peptide concentrations of 2, 4, 8, 10, 15, 20 and 40 μM.The cell viability of 3T3 cell lines is 69%, 77%, 62%, 47%, 21%, 15% and 15% at peptide concentratio", "Binding Target": "Not found", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Amidation", "Stereochemistry": "L", "Structure Description": "The peptide adopts helical conformation with some random structure at the N- and C-terminals. In sodium phosphate buffer (PBS) and water they have a predominantly random structure, but in 20 mM sodium dodecyl sulfate (SDS) and 2,2,2-trifluoroethanol (TFE) they have a typical alpha-helix structure.", "Formula": "C99H161N21O19", "Mass": 1949.47, "PI": 10.48, "Net Charge": 4, "Hydrophobicity": 0.96, "Half Life": "Mammalian:1.1 hourYeast:3 minE.coli:2 min", "Function": "Antibacterial activity against the Gram-positive and Gram-negative bacteria. Antifungal activity against yeasts.Antiparasitic Activity against epimastigote forms of Trypanosoma cruzi. Antiproliferative Activity against HeLa cells.", "Literature": [{"Title": "Analogs of the Scorpion Venom Peptide Stigmurin Structural Assessment, Toxicity, and Increased Antimicrobial Activity.", "Pubmed ID": "29670004", "Reference": "Toxins (Basel). 2018 Apr 18;10(4). pii E161.", "Author": "Parente AMS, Daniele-Silva A, Furtado AA, Melo MA, Lacerda AF, Queiroz M, Moreno C, Santos E, Rocha HAO, Barbosa EG, Carvalho E, Silva-Júnior AA, Silva MS, Fernandes-Pedrosa MF.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=29670004"}, {"Title": "Analogs of the Scorpion Venom Peptide Stigmurin: Structural Assessment, Toxicity, and Increased Antimicrobial Activity", "Pubmed ID": "", "Author": "Parente AMS, Daniele-Silva A, Furtado AA, Melo MA, Lacerda AF, Queiroz M, Moreno C, Santos EC, Rocha"}], "Frequent Amino Acids": "KFL", "Absent Amino Acids": "CDEHMNOQRTUWY", "Basic Residues": 4, "Acidic Residues": 0, "Hydrophobic Residues": 11, "Polar Residues": 7, "Positive Residues": 4, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_N_10277", "Similarity": 1.0, "Sequence": "KFFKFFKFFK"}, {"SPADE_ID": "SPADE_UN_29255", "Similarity": 1.0, "Sequence": "KFFKFFKFFK"}, {"SPADE_ID": "SPADE_UN_11719", "Similarity": 0.9411764705882353, "Sequence": "FFSLIPKLVKGLISAFK"}]}}}